JP5147207B2 - Hydrogel wound dressing - Google Patents
Hydrogel wound dressing Download PDFInfo
- Publication number
- JP5147207B2 JP5147207B2 JP2006256893A JP2006256893A JP5147207B2 JP 5147207 B2 JP5147207 B2 JP 5147207B2 JP 2006256893 A JP2006256893 A JP 2006256893A JP 2006256893 A JP2006256893 A JP 2006256893A JP 5147207 B2 JP5147207 B2 JP 5147207B2
- Authority
- JP
- Japan
- Prior art keywords
- hydrogel
- wound
- wound dressing
- weight
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000017 hydrogel Substances 0.000 title claims description 50
- 239000000853 adhesive Substances 0.000 claims description 21
- 230000001070 adhesive effect Effects 0.000 claims description 21
- 230000035699 permeability Effects 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 229920006264 polyurethane film Polymers 0.000 claims description 16
- 229920002125 Sokalan® Polymers 0.000 claims description 14
- 230000006378 damage Effects 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 239000004584 polyacrylic acid Substances 0.000 claims description 10
- 230000002209 hydrophobic effect Effects 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 7
- 229920001059 synthetic polymer Polymers 0.000 claims description 7
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 5
- 238000010227 cup method (microbiological evaluation) Methods 0.000 claims description 5
- 239000005001 laminate film Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 230000033001 locomotion Effects 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 230000036961 partial effect Effects 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 description 78
- 208000027418 Wounds and injury Diseases 0.000 description 78
- 238000012360 testing method Methods 0.000 description 23
- 210000000416 exudates and transudate Anatomy 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 16
- 239000000499 gel Substances 0.000 description 13
- 230000035876 healing Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 9
- -1 polypropylene Polymers 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920006267 polyester film Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229940037001 sodium edetate Drugs 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003522 acrylic cement Substances 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 2
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 238000007718 adhesive strength test Methods 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical class [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 229910001701 hydrotalcite Inorganic materials 0.000 description 1
- 229960001545 hydrotalcite Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Chemical class 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229920006302 stretch film Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Description
本発明は、伸縮性に優れ、創傷面の滲出液の吸収性を有し、創傷面の治癒を促進するのに適した湿潤環境を長時間維持することができ、そして創傷被覆材の交換時に痛みや再生された皮膚の損傷のおそれのないハイドロゲル創傷被覆材に関する。 The present invention has excellent elasticity, absorbs wound surface exudate, can maintain a moist environment suitable for promoting wound surface healing for a long time, and when changing the wound dressing The present invention relates to a hydrogel wound dressing that does not cause pain or damage to regenerated skin.
従来、創傷面の治療剤として、ガーゼ、粉末剤、スプレー剤、軟膏、クリーム剤、スポンジ剤等が使用されてきた。これらの内大部分のものは、創傷面からの滲出液を吸収することによって創傷部位を乾燥させ、治癒させるためのものであった。しかしながら、近年、創傷部位を乾燥させるよりも滲出液を創傷面に維持させ、適度な湿潤環境に保つことによって、創傷治癒の促進効果が見られることが判明し、創傷部位を適度な湿潤環境に維持させる必要性が認識され、それに適した創傷被覆材が開発されてきた。
創傷被覆材の要件として、吸収性、湿潤維持、細菌侵入防止、細菌増殖防止、機械的強度、粘着性、透明性などが求められている。機械的強度とは、滲出液を吸収しても該被覆材がバラバラにならず、交換時において創傷部に小片が残らないことを言う。透明性は、患部の観察のために必要である。
創傷被覆材として、ポリウレタンフィルム、ハイドロコロイド、PVAハイドロゲル、アルギン酸塩ゲル等が知られている。
Conventionally, gauze, powders, sprays, ointments, creams, sponges and the like have been used as therapeutic agents for wound surfaces. Most of these were intended to dry and heal wound sites by absorbing exudate from the wound surface. However, in recent years, it has been found that by maintaining exudate on the wound surface rather than drying the wound site and maintaining an appropriate moist environment, an effect of promoting wound healing can be seen, making the wound site an appropriate moist environment. The need to maintain has been recognized and suitable wound dressings have been developed.
As requirements for the wound dressing, absorption, wet maintenance, prevention of bacterial invasion, prevention of bacterial growth, mechanical strength, adhesiveness, transparency and the like are required. The mechanical strength means that even when the exudate is absorbed, the covering material does not fall apart, and small pieces do not remain in the wound part at the time of replacement. Transparency is necessary for observation of the affected area.
Known wound dressings include polyurethane films, hydrocolloids, PVA hydrogels, alginate gels, and the like.
上記の創傷被覆材のうち、ポリウレタンフィルムにアクリル系粘着剤を塗工した創傷被覆材は、伸縮性に非常に優れているが、滲出液の吸収性が全くないために滲出液が滲出している創傷面にこれを適応すると、液だまりが起こりドレナージが必要である。また、粘着力も強いため、交換時に痛みを伴ったり、再生された皮膚を損傷するおそれがある(特許文献1、2、3参照)。 Among the above wound dressings, the wound dressing material in which an acrylic adhesive is applied to the polyurethane film is very excellent in stretchability, but exudates are exuded because there is no absorbability of exudates. When this is applied to a wound surface, a puddle occurs and drainage is required. Moreover, since adhesive force is also strong, there exists a possibility of causing pain at the time of replacement | exchange, or damaging the reproduced | regenerated skin (refer patent document 1, 2, 3).
ハイドロコロイドは、疎水性基剤中に含有された親水性コロイド粒子が膨潤することによって滲出液を吸収性するので、吸収性には優れているが、交換時に創傷面にゲル状物質が残りやすい。また、半透明から不透明のものが多く、創傷面を観察することが難しい。更に粘着力も強いため、交換時に痛みを伴ったり、再生された皮膚を損傷するおそれがある。
PVAハイドロゲルは、製剤中に約80%の精製水を含んでいるので、湿潤環境の維持、冷却効果による疼痛緩和、そして透明性には非常に優れているが、粘着力がほとんどないため、包帯やサージカルテープなどの固定材が必要である。またPVAハイドロゲルに粘着力を持たせるために、放射線照射などの工夫を施す提案もなされている(特許文献4参照)が、未だ粘着力は充分でない。
Hydrocolloid absorbs exudate when the hydrophilic colloid particles contained in the hydrophobic base swell, so that it absorbs exudate and is excellent in absorbability. However, a gel-like substance tends to remain on the wound surface during replacement. In addition, many are translucent to opaque and it is difficult to observe the wound surface. Furthermore, since the adhesive strength is strong, there is a risk that it may be painful at the time of replacement or damage the regenerated skin.
PVA hydrogel contains approximately 80% purified water in the formulation, so it is very excellent in maintaining a moist environment, reducing pain due to cooling effect, and transparency, but has little adhesive strength. Fixing materials such as bandages and surgical tape are required. Moreover, in order to give PVA hydrogel adhesive strength, proposals have been made to devise radiation irradiation or the like (see Patent Document 4), but the adhesive strength is still insufficient.
アルギン酸塩ゲルは、止血性、滲出液の吸収性には優れているが、滲出液によってゲル化するため交換時には創傷面にゲル状物質が残りやすく、また開放系であるので、湿潤維持、細菌侵入防止、細菌増殖防止のためにフィルム材でカバーする等の必要性がある(特許文献5参照)。 Alginate gel is excellent in hemostasis and exudate absorption, but gels with exudate, so gel substances are likely to remain on the wound surface during replacement. There is a need to cover with a film material to prevent invasion and bacterial growth (see Patent Document 5).
従って、伸縮性に優れ、滲出液の吸収性を有し、創傷面の治癒を促進するのに適した湿潤環境を長時間維持することができ、創傷被覆材の交換時に痛みや再生された皮膚を損傷するおそれのないハイドロゲル創傷被覆材が望まれていた。
本発明は、伸縮性に優れ、創傷面の滲出液の吸収性を有し、創傷面の治癒を促進するのに適した湿潤環境を長時間維持することができ、そして創傷被覆材の交換時に痛みや再生された皮膚の損傷のおそれのないハイドロゲル創傷被覆材を提供することにある。 The present invention has excellent elasticity, absorbs wound surface exudate, can maintain a moist environment suitable for promoting wound surface healing for a long time, and when changing the wound dressing It is an object of the present invention to provide a hydrogel wound dressing which does not cause pain or damage to the regenerated skin.
上記創傷被覆材を得るために、本発明者らが鋭意検討を行った結果、水溶性合成あるいは半合成高分子、グリセリン、水を含有してなるハイドロゲルをポリウレタンフィルムと疎水性繊維からなる2層のラミネートフィルムに塗布し、その透湿度をJIS Z0208 カップ法による測定値で500〜2000(g/m2/24h)とすることにより、創傷面の保護に優れ、滲出液の吸収性を有し、創傷面の治癒を促進するのに適した湿潤環境を長時間維持することができ、創傷被覆材の交換時等に痛みや再生された皮膚を損傷するおそれがないハイドロゲル創傷被覆材を得られることを見いだし、本発明を完成した。 In order to obtain the above wound dressing, the present inventors have intensively studied. As a result, a hydrogel containing a water-soluble synthetic or semi-synthetic polymer, glycerin and water is composed of a polyurethane film and hydrophobic fibers. It is applied to a laminate film of layers, and its water vapor transmission rate is 500 to 2000 (g / m 2 / 24h) as measured by the JIS Z0208 cup method, providing excellent wound surface protection and exudate absorption. A hydrogel wound dressing that can maintain a moist environment suitable for promoting healing of the wound surface for a long time and does not cause pain or damage to the regenerated skin when replacing the wound dressing. The present invention has been completed by finding out that it can be obtained.
本発明のハイドロゲル創傷被覆材は、創傷面の保護に優れ、滲出液の吸収性を有し、創傷面の治癒を促進するのに適した湿潤環境を長時間維持することができ、創傷被覆材の交換時に痛みや再生された皮膚を損傷するおそれがない等の効果を奏する。 The hydrogel wound dressing of the present invention has excellent wound surface protection, exudate absorbability, can maintain a moist environment suitable for promoting wound surface healing for a long time, There is an effect that there is no possibility of damaging the pain or the regenerated skin when replacing the material.
即ち本発明は、水溶性合成あるいは半合成高分子、グリセリン及び水を含有してなるハイドロゲルがポリウレタンフィルムと疎水性繊維からなる2層のラミネートフィルムに塗布され、その透湿度がJIS Z0208 カップ法による測定で500〜2000(g/m2/24h)であるハイドロゲル創傷被覆材に関する。
またポリウレタンフィルムの厚みが5〜25μmであり、その定荷重伸長率が5%以上である支持体を使用することにより、創傷面の適度な湿潤環境の維持を可能にしながら、創傷面の観察ができる程度の透明性を保つことができる。さらにポリウレタンフィルムと疎水性繊維からなる2層のラミネートフィルムの透湿度をJIS L1099 塩化カルシウム法による測定で200〜5000(g/m2/24h)の範囲内とすることにより、適度な湿潤環境の長時間にわたる維持、及び蒸れによる皮膚刺激の防止といった効果も得ることができる。
That is, in the present invention, a hydrogel containing a water-soluble synthetic or semi-synthetic polymer, glycerin and water is applied to a two-layer laminate film composed of a polyurethane film and a hydrophobic fiber, and the moisture permeability is JIS Z0208 cup method. It is related with the hydrogel wound dressing which is 500-2000 (g / m < 2 > / 24h) by the measurement by.
In addition, by using a support having a polyurethane film thickness of 5 to 25 μm and a constant load elongation of 5% or more, the wound surface can be observed while maintaining an appropriate moist environment. Transparency as much as possible can be maintained. Furthermore, by setting the moisture permeability of the two-layer laminate film made of polyurethane film and hydrophobic fiber within the range of 200 to 5000 (g / m 2 / 24h) as measured by the JIS L1099 calcium chloride method, Effects such as maintenance for a long time and prevention of skin irritation due to stuffiness can also be obtained.
そしてハイドロゲル中の水分含量を30〜80%とすることで適度な粘着性を持つことができる。すなわち創傷面における適度な湿潤環境の維持と創傷被覆材の交換時の、剥離による皮膚損傷の防止効果を兼ね備えることができる。それに加え、滲出液の高い吸収性を確保し得る利点を有している。 And it can have moderate adhesiveness by making the water content in a hydrogel into 30 to 80%. In other words, it is possible to combine the maintenance of a moderate moist environment on the wound surface and the effect of preventing skin damage due to peeling when the wound dressing is replaced. In addition, it has the advantage of ensuring high absorbency of exudate.
以下に本発明をより詳細に説明する。
本発明のハイドロゲル創傷被覆材は、その透湿度がJIS Z0208 カップ法による測定値で500〜2000(g/m2/24h)であり、好ましくは700〜1500(g/m2/24h)である。透湿度が500(g/m2/24h)未満の場合は、蒸れによる皮膚刺激が発生する恐れがあり、好ましくない。また2000(g/m2/24h)より大きいと創傷面を適度な湿潤環境に長時間維持することができなくなり、好ましくない。
Hereinafter, the present invention will be described in more detail.
The hydrogel wound dressing of the present invention has a moisture permeability of 500 to 2000 (g / m 2 / 24h), preferably 700 to 1500 (g / m 2 / 24h) as measured by the JIS Z0208 cup method. is there. If the moisture permeability is less than 500 (g / m 2 / 24h ), there is a possibility that skin irritation due to sweatiness may occur, which is undesirable. Also it can not be maintained 2000 (g / m 2 / 24h ) larger than long wound surface to a suitable moist environment, is not preferred.
本発明のポリウレタンフィルムを構成するポリウレタン樹脂は、エーテル系、エステル系等の一般的なウレタン樹脂を用いることができ、特に制限されることはない。
本発明で使用するポリウレタンフィルムは、その厚みが好ましくは5〜25μmであり、定荷重伸長率が好ましくは5%以上である。ポリウレタンフィルムの厚みは5μm未満だと機械的強度不足及びピンホールの増大により創傷面を適度な湿潤環境に維持することができないため、好ましくない。逆に25μmより厚くなると定荷重伸長率が5%未満となり、伸縮性が損なわれるため、創傷面の保護が難しくなる。また透明性も低下するため、創傷面の観察ができなくなり、好ましくない。
The polyurethane resin constituting the polyurethane film of the present invention can be a general urethane resin such as an ether or ester, and is not particularly limited.
The polyurethane film used in the present invention preferably has a thickness of 5 to 25 μm and a constant load elongation rate of preferably 5% or more. If the thickness of the polyurethane film is less than 5 μm, the wound surface cannot be maintained in an appropriate moist environment due to insufficient mechanical strength and increased pinholes, which is not preferable. On the other hand, if the thickness is greater than 25 μm, the constant load elongation rate is less than 5%, and the stretchability is impaired, so that it is difficult to protect the wound surface. Moreover, since transparency also falls, observation of a wound surface becomes impossible and it is not preferable.
ポリウレタンフィルムにラミネートする疎水性繊維としては、ポリエステル、ナイロン、アクリル、ポリプロピレン、ポリエチレン等を使用することができる。
このように作製されたポリウレタンフィルムと疎水性繊維からなる2層のラミネートフィルムの透湿度は、創傷面の治癒を促進するのに適した湿潤環境を長時間保てるようにJIS L1099 塩化カルシウム法による測定で200〜5000(g/m2/24h)の範囲内であることが好ましく、より好ましくは300〜3000(g/m2/24h)である。透湿度が5000(g/m2/24h)より大きいと湿潤環境を長時間保てず、創傷面の治癒の促進効果が低下する。また、200(g/m2/24h)未満の場合は、蒸れによる皮膚刺激が発生する恐れがあり、好ましくない。
As the hydrophobic fiber laminated on the polyurethane film, polyester, nylon, acrylic, polypropylene, polyethylene, or the like can be used.
The moisture permeability of the two-layer laminate film made of polyurethane film and hydrophobic fibers prepared in this way is measured by the JIS L1099 calcium chloride method so that a moist environment suitable for promoting wound healing can be maintained for a long time. in is preferably in the range of 200~5000 (g / m 2 / 24h ), more preferably 300~3000 (g / m 2 / 24h ). Moisture permeability can not be maintained for a long time 5000 (g / m 2 / 24h ) larger than a wet environment and reduced effect of promoting healing of wound surface. Moreover, when less than 200 (g / m < 2 > / 24h), there exists a possibility that the skin irritation | stimulation by steaming may generate | occur | produce, and it is not preferable.
本発明に用いられる水溶性合成あるいは半合成高分子としては例えば、ポリアクリル酸、ポリアクリル酸ナトリウム、ポリアクリル酸部分中和物、ポリアクリル酸デンプン、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシエチルセルロース、メチルセルロース、カルメロースナトリウム、カルボキシビニルポリマー、N−ビニルアセトアミド共重合体等が挙げられ、これらを単独又は2種以上の組み合わせで用いることができる。特に、カルボキシビニルポリマー、ポリアクリル酸、ポリアクリル酸部分中和物及びカルメロースナトリウムの組合せが好ましい。 Examples of the water-soluble synthetic or semi-synthetic polymer used in the present invention include polyacrylic acid, sodium polyacrylate, partially neutralized polyacrylic acid, starch polyacrylate, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, Examples thereof include methyl cellulose, carmellose sodium, carboxyvinyl polymer, N-vinylacetamide copolymer, and the like. These can be used alone or in combination of two or more. Particularly preferred is a combination of carboxyvinyl polymer, polyacrylic acid, partially neutralized polyacrylic acid and carmellose sodium.
ハイドロゲル中の上記水溶性合成あるいは半合成高分子の配合量は、好ましくは3〜20重量%であり、より好ましくは、5〜15重量%である。配合量が3重量%未満では、ゲル粘度が低すぎて貼付剤として成形することが難しくなり、20重量%を越えると水溶性合成あるいは半合成高分子がゲル中で均一に溶解せず、良好なゲルが形成されないため、好ましくない。 The amount of the water-soluble synthetic or semi-synthetic polymer in the hydrogel is preferably 3 to 20% by weight, more preferably 5 to 15% by weight. If the blending amount is less than 3% by weight, the gel viscosity is too low to be molded as a patch, and if it exceeds 20% by weight, the water-soluble synthetic or semi-synthetic polymer does not dissolve uniformly in the gel and is good. This is not preferable because no gel is formed.
ハイドロゲル中の水の配合量は、ゲル重量に対して好ましくは30〜80重量%、より好ましくは40〜75重量%である。含水量が80重量%を超えた場合、滲出液の吸収性が低下するため、好ましくない。また、30重量%未満では、粘着力が強くなりすぎて、創傷被覆材の交換時に痛みや再生された皮膚を損傷するおそれや、皮膚への保湿性が減じるため創傷面の治癒を促進するのに適した湿潤環境に維持することができなくなり好ましくない。 The amount of water in the hydrogel is preferably 30 to 80% by weight, more preferably 40 to 75% by weight, based on the gel weight. When the water content exceeds 80% by weight, the exudate absorbability is lowered, which is not preferable. Also, if it is less than 30% by weight, the adhesive strength becomes too strong, which may damage the pain or the regenerated skin when replacing the wound dressing, and promote the healing of the wound surface because the moisture retention on the skin is reduced. It is not preferable because it cannot be maintained in a moist environment suitable for the above.
また、ハイドロゲル中のグリセリン配合量は、好ましくは10〜40重量%、より好ましくは15〜30重量%である。ハイドロゲル中のグリセリン配合量が10重量%未満では、皮膚に対する保湿性が低下するため創傷面の治癒を促進するのに適した湿潤環境に維持することができなくなる。また、ハイドロゲル中のグリセリン配合量が40重量%より多くなるとゲル表面に維持出来なくなったグリセリンが浮き出し現象を起こし、貼付時にべとつきが生じたり粘着力が低下するといった問題が生じる。 Moreover, the glycerin compounding quantity in hydrogel becomes like this. Preferably it is 10 to 40 weight%, More preferably, it is 15 to 30 weight%. If the blended amount of glycerin in the hydrogel is less than 10% by weight, the moisture retention on the skin is lowered, so that it is impossible to maintain a moist environment suitable for promoting healing of the wound surface. In addition, when the amount of glycerin in the hydrogel exceeds 40% by weight, the glycerin that cannot be maintained on the surface of the gel is raised, causing problems such as stickiness at the time of sticking and reduced adhesive strength.
ハイドロゲルを構成する上記以外の組成については本発明の効果を阻害しない限り、特に制限はなく、例えば、賦形剤、保湿剤、安定化剤、架橋剤などを配合させることができる。
賦形剤として例えば、カオリン、酸化チタン、無水ケイ酸、酸化亜鉛、ベントナイト等を単独又は2種以上の組み合わせで用いることができる。しかし、ハイドロゲルを創傷面に貼付した時、創傷面が観察できるようにハイドロゲルに透明性を持たせる必要性があるため、特に無水ケイ酸が好ましく、その配合量は0.1〜5重量%が好ましい。
The composition other than the above that constitutes the hydrogel is not particularly limited as long as the effects of the present invention are not impaired, and for example, an excipient, a humectant, a stabilizer, a crosslinking agent, and the like can be blended.
As the excipient, for example, kaolin, titanium oxide, silicic anhydride, zinc oxide, bentonite and the like can be used alone or in combination of two or more. However, since it is necessary to make the hydrogel transparent so that the wound surface can be observed when the hydrogel is applied to the wound surface, silicic anhydride is particularly preferable, and its blending amount is 0.1 to 5 wt. % Is preferred.
グリセリン以外の保湿剤としては例えば、D−ソルビトール液、1,3−ブチレングリコール、ジプロピレングリコール、ポリエチレングリコール、ポリプロピレングリコール、DL-ピロリドンカルボン酸ナトリウム液等を単独又は2種以上の組み合わせで用いることができ、その配合量は10〜30重量%が好ましい。 As humectants other than glycerin, for example, D-sorbitol liquid, 1,3-butylene glycol, dipropylene glycol, polyethylene glycol, polypropylene glycol, DL-pyrrolidone carboxylate sodium liquid, etc. are used alone or in combination of two or more. The blending amount is preferably 10 to 30% by weight.
また、ハイドロゲルのpHは、皮膚刺激性の点からpH3.5〜6.5の範囲が好ましく、さらにはpH4.0〜5.5の範囲がより好ましい。pH調節剤として、酒石酸、亜硫酸水素ナトリウム、エデト酸塩などが用いられる。 The pH of the hydrogel is preferably in the range of pH 3.5 to 6.5 from the viewpoint of skin irritation, and more preferably in the range of pH 4.0 to 5.5. As the pH adjuster, tartaric acid, sodium bisulfite, edetate and the like are used.
架橋剤として例えば、乾燥水酸化アルミニウムゲル、アルミニウムグリシネート、ジヒドロキシアルミニウムアミノアセテート、合成ヒドロタルサイト、メタケイ酸アルミン酸金属塩などの多価金属化合物等を単独又は2種以上の組み合わせで用いることができる。その配合量は、その種類に応じて異なるが、0.001〜1重量%が好ましい。
また、必要に応じて防腐剤、抗酸化剤、可塑剤、乳化剤、界面活性剤等を配合させることができる。
For example, a polyhydric metal compound such as dry aluminum hydroxide gel, aluminum glycinate, dihydroxyaluminum aminoacetate, synthetic hydrotalcite, or metal salt of metasilicic acid aluminate may be used alone or in combination of two or more as the crosslinking agent. it can. The blending amount varies depending on the type, but is preferably 0.001 to 1% by weight.
Moreover, antiseptic | preservative, antioxidant, a plasticizer, an emulsifier, surfactant, etc. can be mix | blended as needed.
本発明のハイドロゲル創傷被覆材は、創傷部に適用したときには皮膚の動きに追随できる程度の粘着力が必要であり、またその交換時では再生した皮膚を損傷しない程度の粘着力が求められる。従って、本発明のハイドロゲル創傷被覆材では適用時(吸水前)の粘着力はボールナンバーが8〜12であり、交換時(8時間吸水後)のボールナンバーが3以下に設定される。適用時のボールナンバーが8〜12であれば創傷部に適用したとき皮膚の動き追随できる適度な粘着力を持つことができる。またボールナンバーが8未満であれば初期粘着力が低いため可動する創傷部に適用したときに、皮膚の動きに追随することができず、すぐに剥がれてくるという問題が起こるため好ましくない。また、12を越えると創傷部に適用したとき、粘着力が強すぎるために皮膚刺激が起こる可能性があり、好ましくない。一方、交換時のボールナンバーが3以下であれば交換時の痛みや再生された皮膚を損傷することのない粘着力であり、3を越えると粘着力が高すぎるために交換時の痛みや、再生された皮膚を損傷する可能性があり好ましくない。
なお、上記ボールナンバーの値はJIS Z0237のボールタック試験法に準じて行なう傾斜角30°でのボールタック試験法より試験を行った場合の値を意味する。
The hydrogel wound dressing of the present invention is required to have an adhesive strength that can follow the movement of the skin when applied to a wound part, and is required to have an adhesive strength that does not damage the regenerated skin at the time of replacement. Therefore, in the hydrogel wound dressing of the present invention, the ball number of the adhesive force at the time of application (before water absorption) is 8 to 12, and the ball number at the time of replacement (after water absorption for 8 hours) is set to 3 or less. If the ball number at the time of application is 8 to 12, it can have an appropriate adhesive force that can follow the movement of the skin when applied to the wound. On the other hand, if the ball number is less than 8, the initial adhesive force is low, so that when applied to a movable wound part, it is not preferable because it cannot follow the movement of the skin and peels off immediately. On the other hand, if it exceeds 12, when applied to a wound part, the adhesive force is too strong, which may cause skin irritation, which is not preferable. On the other hand, if the ball number at the time of replacement is 3 or less, it is an adhesive force that does not damage the pain or regenerated skin, and if it exceeds 3, the adhesive force is too high, It may damage the regenerated skin, which is not preferable.
The value of the ball number means a value obtained when the test is performed by the ball tack test method at an inclination angle of 30 ° according to the ball tack test method of JIS Z0237.
ハイドロゲル表面を被覆するプラスチックフィルムとしては、ポリエチレン、ポリプロピレン、ポリエステル、ポリ塩化ビニル又はこれらの表面をシリコーン処理、コロナ放電処理、凹凸処理、プラズマ処理等をしたものを用いることができる。 As the plastic film covering the surface of the hydrogel, polyethylene, polypropylene, polyester, polyvinyl chloride, or a film obtained by subjecting these surfaces to silicone treatment, corona discharge treatment, uneven treatment, plasma treatment or the like can be used.
本発明のハイドロゲル創傷被覆材の製造方法は、特に限定はなく公知の製造方法で製造することができる。例えば、前記の様な構成で組成されたハイドロゲルを支持体上に展延し、ハイドロゲル表面をプラスチックフィルムで被覆することにより、ハイドロゲル創傷被覆材を成形することができる。
必要に応じては、通常行われている滅菌方法である放射線滅菌、電子線滅菌、エチレンオキシド滅菌等を行うことができる。
The manufacturing method of the hydrogel wound dressing of the present invention is not particularly limited and can be manufactured by a known manufacturing method. For example, a hydrogel wound dressing can be formed by spreading a hydrogel composed as described above on a support and coating the surface of the hydrogel with a plastic film.
If necessary, radiation sterilization, electron beam sterilization, ethylene oxide sterilization, and the like, which are conventionally performed, can be performed.
以下に、実施例及び比較例を示し、本発明をさらに具体的に説明するが、本発明はこれらの実施例に限定されるものではない。 Hereinafter, the present invention will be described more specifically with reference to examples and comparative examples. However, the present invention is not limited to these examples.
実施例1
精製水適量にカルボキシビニルポリマー(1.6g)を溶解した後、D―ソルビトール液(20g)加え、均一になるまで混合した。更にポリアクリル酸(0.3g)、酒石酸(1.2g)、濃グリセリン(20.7g)、カルメロースナトリウム(3.5g)、ポリアクリル酸部分中和物(4g)、無水ケイ酸(0.1g)、ヒマシ油(1.5g)、ジヒドロキシアルミニウムアミノアセテート(0.07g)、エデト酸ナトリウム(0.08g)、精製水(適量)を均一に混合してハイドロゲルを調製した。このハイドロゲルをウレタン(20μm)/ナイロンエラストマー(25g/m2)上に展延し、ゲル表面をポリエステルフィルムで被覆することによりハイドロゲル創傷被覆材を成型した。
Example 1
After dissolving carboxyvinyl polymer (1.6 g) in an appropriate amount of purified water, D-sorbitol solution (20 g) was added and mixed until uniform. Furthermore, polyacrylic acid (0.3 g), tartaric acid (1.2 g), concentrated glycerin (20.7 g), carmellose sodium (3.5 g), polyacrylic acid partial neutralized product (4 g), silicic anhydride (0 0.1 g), castor oil (1.5 g), dihydroxyaluminum aminoacetate (0.07 g), sodium edetate (0.08 g), and purified water (appropriate amount) were uniformly mixed to prepare a hydrogel. The hydrogel was spread on urethane (20 μm) / nylon elastomer (25 g / m 2 ) and the gel surface was covered with a polyester film to form a hydrogel wound dressing.
実施例2
表1に掲げる成分を用いて、実施例1と同様にしてハイドロゲルを調製し、これをウレタン(20μm)/ナイロントリコット(支持体)に展延し、ゲル表面をポリエステルフィルムで被覆することによりハイドロゲル創傷被覆材を成型した。
Example 2
By preparing the hydrogel in the same manner as in Example 1 using the components listed in Table 1, spreading this on urethane (20 μm) / nylon tricot (support), and covering the gel surface with a polyester film A hydrogel wound dressing was molded.
実施例3
精製水適量に無水ケイ酸(0.5g)を溶解した後、尿素(1.0g)、エデト酸ナトリウム(0.08g)、ヒマシ油(0.5g)を加え、均一になるまで混合した。更に20%ポリアクリル酸 水溶液(15.0g)、酒石酸(0.3g)、濃グリセリン(16.0g)、カルメロースナトリウム(4.0g)、ポリアクリル酸部分中和物(5.0g)、メタケイ酸アルミン酸マグネシウム(0.06g)、乾燥水酸化アルミニウムゲル(0.02g)、精製水 適量を均一に混合してハイドロゲルを調製した。このハイドロゲルをウレタン(20μm)/ナイロンエラストマー(25g/m2)上に展延し、ゲル表面をポリエステルフィルムで被覆することによりハイドロゲル創傷被覆材を成型した。
Example 3
After silicic anhydride (0.5 g) was dissolved in an appropriate amount of purified water, urea (1.0 g), sodium edetate (0.08 g), and castor oil (0.5 g) were added and mixed until uniform. Furthermore, 20% polyacrylic acid aqueous solution (15.0 g), tartaric acid (0.3 g), concentrated glycerin (16.0 g), carmellose sodium (4.0 g), partially neutralized polyacrylic acid (5.0 g), A hydrogel was prepared by uniformly mixing magnesium aluminate metasilicate (0.06 g), dry aluminum hydroxide gel (0.02 g) and an appropriate amount of purified water. The hydrogel was spread on urethane (20 μm) / nylon elastomer (25 g / m 2 ) and the gel surface was covered with a polyester film to form a hydrogel wound dressing.
比較例1及び2
表1に掲げる成分を用いて、実施例1と同様にして実施例1と同様にしてハイドロゲルを調製し、これを表1記載のそれぞれのPET不織布(支持体)に展延し、被覆材を成型し、これらを以下の比較試験に供した。
Comparative Examples 1 and 2
Using the components listed in Table 1, a hydrogel was prepared in the same manner as in Example 1 in the same manner as in Example 1. The hydrogel was spread on each PET nonwoven fabric (support) described in Table 1, and a covering material was prepared. Were subjected to the following comparative test.
比較例3:デュオアクチブ登録商標(外層:ポリウレタンフィルム、粘着層:親水性コロイドと粒子疎水性ポリマー、剥離紙:シリコーン剥離紙)
比較例4:オプサイト商標(ポリウレタンフィルムにアクリル系接着剤を塗布したもの)
比較例5:ビューゲル登録商標(支持体:ポリエチレン、ハイドロゲル吸収体:ポビトン、PVA、フェノキシエタノール、水(80%))
Comparative example 3: Duoactive registered trademark (outer layer: polyurethane film, adhesive layer: hydrophilic colloid and particle hydrophobic polymer, release paper: silicone release paper)
Comparative example 4: Opsite trademark (polyurethane film coated with acrylic adhesive)
Comparative Example 5: View gel registered trademark (support: polyethylene, hydrogel absorber: poviton, PVA, phenoxyethanol, water (80%))
試験例1
実施例1〜3、及び比較例1〜5の創傷被覆材を用いて伸縮性、透湿性、吸水性、粘着力を以下の試験方法に従って測定した。測定値は、それぞれ3回測定し、その平均値を求めたものである。結果を表2に示す。
Test example 1
Using the wound dressings of Examples 1 to 3 and Comparative Examples 1 to 5, stretchability, moisture permeability, water absorption, and adhesive strength were measured according to the following test methods. Each measured value was measured three times and the average value was obtained. The results are shown in Table 2.
伸縮性試験
伸縮性試験は、JIS L1096の一般織物試験方法の伸縮織物に準拠して実施した。試験材料を2×6cmに裁断し、4cm間隔で印を付けた(L0)。ラインの外側にクリップをつけて、100g定荷重をかけ、印間の距離を測定し(L1)、次式により
伸長率を算出した。
伸長率(%)=(L0−L1)/L0×100
L0:もとの印間の長さ(4cm)
L1:100g定荷重をかけたときの印間の長さ(cm)
Elasticity test The elasticity test was carried out in accordance with the elastic fabric of the general textile test method of JIS L1096. The test material was cut into 2 × 6 cm and marked at 4 cm intervals (L 0 ). A clip was attached to the outside of the line, a constant load of 100 g was applied, the distance between the marks was measured (L 1 ), and the elongation percentage was calculated by the following formula.
Elongation rate (%) = (L 0 −L 1 ) / L 0 × 100
L 0 : Length between original marks (4 cm)
L 1 : Length between marks when a constant load of 100 g is applied (cm)
透湿性試験
透湿性試験は、JIS Z0208のカップ法に準拠して実施した。ガラス容器(内径:56mm、深さ11mm)に精製水約10mLを入れ、試験材料を直径80mmの円形に裁断し(試験片)、膏体面を内側にしてガラス容器開口部を覆い、ガラス容器端部をパラフィン系の伸縮フィルムにて密封し、この重量を測定した(W0)。次に40℃−75%の恒温恒湿器に24時間静置し、放冷後の重量を精密に測定し(W1)、次式により透湿度を算出した。
透湿度(g/m2・24h)=(W0−W1)×10000÷A
W0:試験前重量(g)
W1:試験後重量(g)
A:ガラス容器の開口部の面積(26.4cm2)
Moisture permeability test The moisture permeability test was performed according to the cup method of JIS Z0208. About 10 mL of purified water is put into a glass container (inner diameter: 56 mm, depth: 11 mm), the test material is cut into a circle with a diameter of 80 mm (test piece), the plaster surface is turned inside, the glass container opening is covered, and the glass container end The part was sealed with a paraffin-based stretch film, and the weight was measured (W 0 ). Next, it was left to stand in a constant temperature and humidity chamber at 40 ° C.-75% for 24 hours, the weight after cooling was measured precisely (W 1 ), and the moisture permeability was calculated by the following formula.
Moisture permeability (g / m 2 · 24h) = (W 0 −W 1 ) × 10000 ÷ A
W 0 : Weight before test (g)
W 1 : Weight after test (g)
A: Area of the opening of the glass container (26.4 cm 2 )
吸水性試験
ステンレス容器(内径:88mm、深さ15mm)に生理食塩水約10mLを入れ、試験材料を4×4cmに裁断し(試験片)、膏体面を内側にして容器内に密封した状態で8時間保存した。容器内に入れる前の試験片重量(W0)と8時間後に取り出した試験片重量(W1)とを比較した。
吸収量:W1−W0
In a water-absorbing test stainless steel container (inner diameter: 88 mm, depth: 15 mm), about 10 mL of physiological saline is put, the test material is cut into 4 × 4 cm (test piece), and the plaster surface is inside and sealed in the container. Stored for 8 hours. The specimen weight (W 0 ) before being put in the container was compared with the specimen weight (W 1 ) taken out after 8 hours.
Absorption amount: W 1 -W 0
粘着力試験
医薬品製造販売指針2005(第IV部医薬品の製造販売承認申請、第1章 粘着力試験)に記載の試験器を用いて、水平に対して30度の斜面上に試験製剤の粘着面を上に向けて置く。上部10cm、下部15cmの部分を適当な紙で覆い、中央に5cmの粘着面を残す。直径3.2mm〜34.9mmの一連のスチールボールを斜面の上端より転がして、中央の粘着面に5秒以上停止するボールの号数を測定した。これを吸水前と8時間吸水後の製剤で評価した。
Adhesive surface of test preparation on a slope of 30 degrees with respect to the horizontal using the test device described in Adhesive Strength Test Drug Manufacturing and Sales Guidelines 2005 (Part IV Application for Manufacturing and Sales Approval of Drugs, Chapter 1 Adhesion Test) Put it facing up. Cover the upper 10 cm and lower 15 cm with appropriate paper, leaving a 5 cm adhesive surface in the center. A series of steel balls having a diameter of 3.2 mm to 34.9 mm was rolled from the upper end of the slope, and the number of balls stopped on the central adhesive surface for 5 seconds or more was measured. This was evaluated by the preparation before water absorption and after water absorption for 8 hours.
試験例2
実施例1〜3及び比較例1〜2で用いた支持体の透湿度をJIS L1099繊維製品の透湿度試験方法にしたがって塩化カルシウム法(A−1法、40℃−90%RH)で測定した結果を表3に示す。
Test example 2
The moisture permeability of the supports used in Examples 1 to 3 and Comparative Examples 1 and 2 was measured by the calcium chloride method (A-1 method, 40 ° C.-90% RH) according to the moisture permeability test method of JIS L1099 textiles. The results are shown in Table 3.
試験例3
実施例1〜3及び比較例1、3、4の創傷被覆材を湿らしたスポンジに上に貼り付けた。そのスポンジを37℃の温水が循環しているステンレス容器に入れた。さらに創傷被覆材とスポンジの間に温湿度センサーを挟み込み貼付部位の温湿度の変化を24時間まで経時的に測定した。その結果を図1に示す。
考察
図1より、市販品である比較例3及び4(製剤の透湿度:343及び377)は、貼付後約2時間目から、適用部位の湿度がほぼ100%となり、この状態が24時間持続した。このことより、比較例3及び4の製剤を創傷面に適用した場合、製剤の透湿度が低すぎるために、創傷面からの滲出液が創傷面に貯留しやすく、創傷面が過度の湿潤状態に維持されるので、長時間貼付した時、貼付部位にムレが生じたり、不快感が生じる恐れがあり、創傷被覆材の取り替えを頻繁に行う必要が生じる等の問題が危惧される。また、比較例1は、貼付直後から適用部位の湿度が低下しはじめ、貼付後2時間目には60%程度となり、この状態が24時間持続した。このことより、透湿度が高い支持体(支持体の透湿度:8541)を用いた比較例1の製剤を創傷部位に適用した場合、貼付直後から創傷面の水分が失われることによって適切な湿潤環境を維持することができず、長時間適用するとハイドロゲルが乾燥することによって、再生された皮膚とハイドロゲルの癒着が起こり、交換時に再生された皮膚を損傷する恐れが危惧される。
それに対して、本発明の実施例1及び3(製剤の透湿度:884及び1367)は、貼付直後から緩やかに湿度が低下し始めるが、約80%の湿度を24時間保持しており、創傷治癒にとって好ましい湿潤状態を長時間維持できることが示されている。
すなわち、支持体の透湿度が200〜5000(g/m2/24h)である支持体とハイドロゲルからなる本発明品を創傷部位に適用した場合、ハイドロゲルが創傷面の滲出液を吸収し、滲出液中の余分な水分を支持体から透過さすことによって滲出液の貯留を防ぐので、創傷面が過度な湿潤状態にならず、創傷面の治癒を促進するのに適した湿潤環境を長時間維持することができることが本試験結果より窺われ、創傷面の治癒を促進するのに適した湿潤環境を保つことが示された。
Test example 3
The wound dressings of Examples 1 to 3 and Comparative Examples 1, 3, and 4 were pasted on a damp sponge. The sponge was put into a stainless steel container in which 37 ° C. warm water was circulating. Further, a temperature / humidity sensor was sandwiched between the wound dressing and the sponge, and the change in temperature / humidity at the applied site was measured over time up to 24 hours. The result is shown in FIG.
Consideration From FIG. 1, in Comparative Examples 3 and 4 (product moisture permeability: 343 and 377), which are commercially available products, the humidity at the application site becomes almost 100% from about 2 hours after application, and this state lasts for 24 hours. did. Accordingly, when the preparations of Comparative Examples 3 and 4 were applied to the wound surface, the moisture permeability of the preparation was too low, so that exudate from the wound surface was likely to accumulate on the wound surface, and the wound surface was in an excessively wet state. Therefore, when applied for a long time, there is a concern that the applied site may become stuffy or uncomfortable, and the wound dressing needs to be replaced frequently. In Comparative Example 1, the humidity at the application site began to decrease immediately after application, and reached about 60% at 2 hours after application, and this state lasted for 24 hours. From this, when the preparation of Comparative Example 1 using a support having a high moisture permeability (moisture permeability of the support: 8541) is applied to the wound site, the moisture on the wound surface is lost immediately after application, so that appropriate moisture is obtained. The environment cannot be maintained, and when applied for a long time, the hydrogel dries out, causing adhesion between the regenerated skin and the hydrogel, which may damage the regenerated skin during replacement.
In contrast, Examples 1 and 3 of the present invention (moisture permeability of the preparations: 884 and 1367) began to gradually decrease in humidity immediately after application, but maintained about 80% humidity for 24 hours. It has been shown that a moist condition favorable for healing can be maintained for a long time.
That is, when the product of the present invention comprising a support and a hydrogel having a moisture permeability of 200 to 5000 (g / m 2 / 24h) is applied to a wound site, the hydrogel absorbs the exudate on the wound surface. This prevents excess water in the exudate from permeating through the support and prevents the exudate from accumulating, so that the wound surface does not become excessively moistened and the moist environment suitable for promoting healing of the wound surface is prolonged. This test result shows that it can be maintained for a long time, and it was shown that a moist environment suitable for promoting healing of the wound surface was maintained.
試験例4
実施例1〜3、及び市販品である比較例3〜5より得られた創傷被覆材をボランティア5名の前腕に4時間貼付し、下記の基準によって皮膚接着性及び剥離時の痛み評価を行った。
Test example 4
The wound dressings obtained from Examples 1 to 3 and Comparative Examples 3 to 5 which are commercially available products are affixed to the forearms of 5 volunteers for 4 hours, and skin adhesion and pain evaluation at the time of peeling are performed according to the following criteria. It was.
皮膚接着性
皮膚接着性については、「剥がれなかった」「半分剥がれた」「剥がれた」の3段階評価を行い、結果を表4に示す。
Skin adhesion The skin adhesion was evaluated in three stages: “not peeled”, “half peeled”, and “peeled”. Table 4 shows the results.
剥離時の痛み
皮膚からの剥離時の痛みについては、「全く痛くない」「あまり痛みを感じない」「痛い」の3段階評価を行い、結果を表5に示す。
Pain at the time of peeling As for the pain at the time of peeling from the skin, a three-step evaluation of “not painful at all”, “not feeling much pain”, and “painful” was performed, and the results are shown in Table 5.
Claims (3)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006256893A JP5147207B2 (en) | 2006-09-22 | 2006-09-22 | Hydrogel wound dressing |
TW097107340A TWI429462B (en) | 2006-09-22 | 2008-03-03 | Hydrogel wound dressing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006256893A JP5147207B2 (en) | 2006-09-22 | 2006-09-22 | Hydrogel wound dressing |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008073287A JP2008073287A (en) | 2008-04-03 |
JP5147207B2 true JP5147207B2 (en) | 2013-02-20 |
Family
ID=39345967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006256893A Active JP5147207B2 (en) | 2006-09-22 | 2006-09-22 | Hydrogel wound dressing |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5147207B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109549778A (en) * | 2019-01-16 | 2019-04-02 | 北京化工大学 | A kind of natural polysaccharide base medical antibacterial bearing hydrocolloid dressing and preparation method thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010009302A (en) * | 2008-02-25 | 2010-09-24 | Teikoku Seiyaku Kk | Wound-covering hydrogel material. |
PL2819627T3 (en) * | 2012-02-29 | 2020-04-30 | Hollister Incorporated | Buffered adhesive compositions for skin-adhering medical products |
CN105705584B (en) * | 2013-11-11 | 2020-05-12 | 日产化学工业株式会社 | Hydrogel-forming composition and hydrogel produced therefrom |
JP6297959B2 (en) * | 2014-09-29 | 2018-03-20 | 積水化成品工業株式会社 | Body sticking tape or body sticking sheet, and manufacturing method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03227919A (en) * | 1990-01-31 | 1991-10-08 | Sekisui Chem Co Ltd | Hydrophilic plaster |
JP2522299Y2 (en) * | 1990-01-31 | 1997-01-08 | 積水化学工業株式会社 | Adhesive patch |
JP2000175959A (en) * | 1998-12-15 | 2000-06-27 | Toyobo Co Ltd | Bandage for wound |
JP5184726B2 (en) * | 2001-10-16 | 2013-04-17 | 帝國製薬株式会社 | Glucosamine-containing cataplasm |
JP4187976B2 (en) * | 2002-02-06 | 2008-11-26 | 株式会社 アルマード | Adhesive bandage |
-
2006
- 2006-09-22 JP JP2006256893A patent/JP5147207B2/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109549778A (en) * | 2019-01-16 | 2019-04-02 | 北京化工大学 | A kind of natural polysaccharide base medical antibacterial bearing hydrocolloid dressing and preparation method thereof |
CN109549778B (en) * | 2019-01-16 | 2020-09-25 | 北京化工大学 | Natural polysaccharide-based medical antibacterial hydrocolloid dressing and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2008073287A (en) | 2008-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009107189A1 (en) | Wound-covering hydrogel material | |
US6635272B2 (en) | Wound dressing and drug delivery system | |
US6458380B1 (en) | Dressing and preparation delivery system | |
EP1341561B1 (en) | Dressings for the treatment of exuding wounds | |
ES2613054T3 (en) | Wound care device | |
JP5878870B2 (en) | How to use wound hydrogel sheet | |
JP2018500137A (en) | Wound dressing with multiple adhesive layers | |
JPH09502367A (en) | Surgical dressing | |
JPH06225932A (en) | Composition that is possible to extrude for local or percutanous medicine distribution | |
JP2006526636A (en) | Hydrophilic adhesive composition for Chinese medicine delivery | |
JP5147207B2 (en) | Hydrogel wound dressing | |
US20070020318A1 (en) | Hydrocolloid materials for use in wound healing | |
JP6290184B2 (en) | Wound dressing | |
EP1601388B1 (en) | Hydrocolloid materials for use in wound healing | |
TWI429462B (en) | Hydrogel wound dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090825 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20090831 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120424 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120619 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20120619 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121030 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121127 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5147207 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151207 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |